Trials with Maya Z

Maya Zlatanova
  • 0,0 (0)
  • Biowissenschaften
  • Zweimonatlich

90% of clinical trials fail, 85% get delayed. Let’s deep dive into the world of planning and running of clinical trials with some of the most experienced and passionate people from the Industry and find out what makes trials more successful or more challenging. Welcome to Trials with Maya Z podcast! Maya Zlatanova, CEO of TrialHub: https://www.linkedin.com/in/mayazlatanova/

  1. 23. März

    The Value of Early Access Programs With Naomi Litchfield

    Naomi Litchfield’s passion for Early Access Programs (EAPs) stems from a personal experience - her sister’s life was saved by an early access drug after being diagnosed with four rare cancers. With nearly 20 years of industry experience, Naomi is now the Director Patient Advocacy at Bionical Emas. In this episode, Naomi and Maya discuss: • What Early Access Programs are and how they work • How EAPs provide hope and open doors for patients in need • The challenges and considerations involved in setting up an EAP Early Access Resources:https://bionicalemas.com/resources/johnson-johnson-guide-to-expanded-access/https://bionicalemas.com/resources/what-is-a-clinical-trial/https://bionicalemas.com/resources/what-is-an-early-access-program/https://bionicalemas.com/resources/what-is-real-world-data/ Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Naomi Litchfield: https://www.linkedin.com/in/naomi-litchfield-499670122/

    24 Min.

  2. 18.03.2025

    The Power of Innovative Trial Designs with Philip Raeth

    Clinical trials are evolving, but are we innovating fast enough? In this episode Maya sits down with Philip Raeth from Palleos Healthcare to explore how new trial designs can challenge the status quo. From adaptive methodologies to efficiency-driven models, we discuss how rethinking trial structure can help us tackle industry-wide hurdles—not just in patient recruitment and retention, but in trial execution, costs, and outcomes. What does the future of clinical trials look like? Tune in as we brainstorm new possibilities. Follow Philip Raeth: https://www.linkedin.com/in/philip-raeth-51911114/Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/

    32 Min.

  3. 31.01.2025

    How to get from Sick Care to Health Care and Rethinking Pharma’s Role with Paul Simms

    Paul Simms is the CEO of Impatient Health and a trailblazing voice in the life sciences industry. Paul is on a mission to push the boundaries of pharma. He works with innovators and early adopters to inject “mutation pressure” into the status quo, ensuring bold ideas and creative solutions make their way into the market. Drawing on his experience as a speaker, event organizer, and consultant, Paul discusses how pharma can evolve to truly align with patients’ needs. Together, with Maya they explore the intersection of innovation, behavioral science, and systemic transformation in healthcare. What You’ll Learn:- Why Paul believes the pharma industry is still in its infancy and how it can grow.- What “mutation pressure” means and how it can drive innovation in pharma.- The critical role of patient engagement and behavioral science in improving healthcare outcomes.- How Paul’s work with major pharma companies has shaped his views on the future of the industry.- Practical lessons from other industries, including fashion and tech, that pharma can adopt.

    36 Min.

  4. 10.12.2024

    Patient Engagement and Standard of Care in Rare Disease Trials with Orit Rindner

    In this episode of Trials with Maya Z, Maya and patient expert and advocate Orit Rindner discuss the intersection of patient needs and clinical trials, highlighting real-world challenges and insights from rare disease research: The impact of standard of care on patient willingness to join clinical trialsChallenges in rare disease trials and patient recruitmentThe importance of aligning clinical trials with patient realities Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Orit Rindner: https://www.linkedin.com/in/oritrindner/   (00:00) - Chapter 1 (00:00) - Introduction to Clinical Research and Patient Advocacy (02:28) - The Intersection of Patient Advocacy and Clinical Trials (04:49) - Patient Perspectives on Clinical Trials (06:47) - Engagement of Patients in Clinical Trial Design (10:11) - Isolated vs multidisciplinary approach (12:27) - The Role of Patient Advocates in Clinical Research (16:12) - Impact of Current Events on Clinical Research in Israel

    19 Min.

  5. 26.11.2024

    Endometriosis: Why Standard Care Isn't Cutting It - Exploring the Gaps with Estelle Jobson

    "Only 1-4% of global healthcare R&D funding is dedicated to female-specific conditions beyond cancer, despite women representing 51% of the population.” Meet Estelle Jobson - an EUPATI Fellow and a patient advocate living with endometriosis. In this episode, Maya and Estelle discuss the limitations of standard care for this chronic condition and call for research that addresses its diverse symptoms.  Why Standard care for endometriosis fails to address patient needs?What is wrong with the current definition of endometriosis?What are the current treatment gaps?Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Estelle Jobson: https://www.linkedin.com/in/estelle-jobson-27389821/ (00:00) - Introduction and Background (02:00) - Lack of Funding for Women's Health Research (05:34) - Challenges in Diagnosing and Treating Endometriosis (09:23) - Limitations of Current Clinical Trials (15:57) - The Need for Fresh Perspectives in Endometriosis Research (25:47) - Including a Wider Range of Patients in Clinical Trials (30:15) - Addressing the Diverse Symptoms of Endometriosis (36:29) - Summary and Conclusion

    40 Min.

  6. 19.11.2024

    RWD Data and Trust in Clinical Trials: Ritesh Patel’s Take

    Join Maya Zlatanova and Ritesh Patel from Finn Partners as they dive into the evolving world of real-world data in clinical trials. Discover the challenges of integrating diverse patient data, the role of social determinants in trial outcomes, and how emerging technologies like AI and digital biomarkers are set to revolutionize the industry. Packed with insights on collaboration and innovation, this episode is a must-listen for anyone passionate about transforming healthcare through data-driven strategies. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Ritesh Patel: https://www.linkedin.com/in/riteshpatel/

    30 Min.

  7. 14.11.2024

    The patient journey in US vs EU and how involving patients early on can help with Ella Balasa

    Ella Balasa has experience on both sides of the research spectrum - as a patient with cystic fibrosis and as a scientist examining antibiotic-resistant bacteria. She is on a mission to amplify patient voices in drug development. In this episode Ella and Maya discuss: Ella’s journey and advising experienceThe difference in the patient journey in US vs. EuropeThe often overlooked challenges in patient access to care Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Ella Balasa: https://www.linkedin.com/in/ella-balasa/

    26 Min.

  8. 29.10.2024

    Real-world data: The Good, the Bad and the Ugly with Jan Poleszczuk from CliniNote

    Meet Jan Poleszczuk, a mathematician turned healthcare innovator and a CTO of CliniNote. In this episode Maya and Jan talk about:- The top 3 challenges hindering the quality of RWD- How CliniNote is helping doctors generate quality data while simplifying their workflow- The potential of RWD in clinical trials  Tune in to explore the good, the bad, and the ugly of Real-World Data and how innovators like Jan Poleszczuk are working to unlock its full potential to improve patient care and drive healthcare innovation. Follow Maya on LinkedIn: https://www.linkedin.com/in/mayazlatanova/ Follow Jan on LinkedIn: https://www.linkedin.com/in/jan-poleszczuk-70200117/ Learn more about CliniNote: https://clininote.com/ (00:00) - Introduction and Background (02:58) - The issues with RWD (06:47) - The Importance of Medical Notes in Real-World Data (11:34) - Automating Transcription of Doctors' Notes (17:09) - Empowering Doctors to Generate High-Quality Data (19:28) - Focusing on Doctors' Jobs to Improve Real-World Data (21:26) - Conclusion and Future of Real-World Data

    22 Min.
Alle anzeigen (53)

Info

90% of clinical trials fail, 85% get delayed. Let’s deep dive into the world of planning and running of clinical trials with some of the most experienced and passionate people from the Industry and find out what makes trials more successful or more challenging. Welcome to Trials with Maya Z podcast! Maya Zlatanova, CEO of TrialHub: https://www.linkedin.com/in/mayazlatanova/

Informationen

  • Erstellt von
    Maya Zlatanova
  • Jahre aktiv
    2024 - 2026
  • Folgen
    53
  • Bewertung
    Unbedenklich
  • Copyright
    © 2026 Maya Zlatanova
  • Sendungswebsite
    Trials with Maya Z